Richard Young
Net worth: 746 344 $ as of 31/05/2026
Net worth: 746 344 $ as of 31/05/2026
Richard A. Young was the founder of Dewpoint Therapeutics, Inc. (2020), CAMP4 Therapeutics Corp.
(2015) as Independent Director, and Syros Pharmaceuticals, Inc. (2011) as Independent Director.
Current jobs include Director at Precede Biosciences, Inc. (2023), Director at Paratus Sciences Corp.
(2021), Professor-Biology at Massachusetts Institute of Technology (1984), and Member at Whitehead Institute for Biomedical Research (1984).
Former jobs include Independent Director at Enzon Pharmaceuticals, Inc. (2011-2013), Independent Director at Omega Therapeutics, Inc. (2017-2024), and Senior Vice President-Steel Mill Product Sales at Eastern Alloys, Inc. Education includes undergraduate degree from Indiana University and doctorate from Yale University (1975).
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2026 | 170,010 ( 0.36% ) | 746 344 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Founder | 01/01/2015 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Corporate Officer/Principal | 01/01/1984 |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | 01/01/1984 |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Founder | 01/10/2020 |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Director/Board Member | 01/11/2021 |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Offers liquid biopsy platform for drug development | Director/Board Member | 01/02/2023 |
| Companies | Position | End |
|---|---|---|
| OMEA THER | Director/Board Member | 06/12/2024 |
| SYROS PHARMACEUTICALS, INC. | Founder | 15/11/2024 |
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Director/Board Member | 20/11/2013 |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eastern Alloys, Inc.
Eastern Alloys, Inc. Other Metals/MineralsNon-Energy Minerals Manufactures and recycles zinc alloys and products | Non-Energy Minerals |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Omega Therapeutics, Inc.
Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biomolecular condensates biotechnology company | Health Technology |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Offers liquid biopsy platform for drug development | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions